(Q55482858)

English

Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells.

scientific article published in June 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

1 reference

based on heuristic

inferred from title

Licia Rivoltini

2

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

author name string

P A Ruffini

1

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

A Silvani

3

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

A Boiardi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

G Parmiani

5

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

publication date

1 June 1993

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

36

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

6

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

409-416

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

https://scigraph.springernature.com/pub.10.1007/bf01742258

0 references

Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TG

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of LAK cells against three-dimensional tumor tissue. In vitro study using multi-cellular human glioma spheroids as targets.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of Serratia marcescens extract in recurrent malignant astrocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of T-cell function by gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary trial of specific targeting therapy against malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of gliomas in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy and monoclonal antibody therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/8500113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01742258

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/8500113

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55482858&oldid=1534682287"